BioMarin Pharmaceutical EBITDA 2006-2019 | BMRN

BioMarin Pharmaceutical annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • BioMarin Pharmaceutical EBITDA for the quarter ending September 30, 2019 was $0.034B, a 201.05% increase year-over-year.
  • BioMarin Pharmaceutical EBITDA for the twelve months ending September 30, 2019 was $-0.028B, a 137.21% decline year-over-year.
  • BioMarin Pharmaceutical 2018 annual EBITDA was $-0.027B, a 136.06% decline from 2017.
  • BioMarin Pharmaceutical 2017 annual EBITDA was $0.076B, a 110.81% decline from 2016.
  • BioMarin Pharmaceutical 2016 annual EBITDA was $-0.705B, a 1049.72% increase from 2015.
BioMarin Pharmaceutical Annual EBITDA
(Millions of US $)
2018 $-27
2017 $76
2016 $-705
2015 $-61
2014 $-40
2013 $-114
2012 $-61
2011 $5
2010 $33
2009 $39
2008 $51
2007 $-56
2006 $-34
2005 $-66
BioMarin Pharmaceutical Quarterly EBITDA
(Millions of US $)
Q3 2019 $34
Q2 2019 $-16
Q1 2019 $-32
Q4 2018 $-14
Q3 2018 $11
Q2 2018 $-5
Q1 2018 $-20
Q4 2017 $88
Q3 2017 $8
Q2 2017 $-19
Q1 2017 $-0
Q4 2016 $-69
Q3 2016 $-31
Q2 2016 $-544
Q1 2016 $-62
Q4 2015 $115
Q3 2015 $-69
Q2 2015 $-52
Q1 2015 $-55
Q4 2014 $-51
Q3 2014 $27
Q2 2014 $-3
Q1 2014 $-13
Q4 2013 $-52
Q3 2013 $-36
Q2 2013 $-6
Q1 2013 $-20
Q4 2012 $-35
Q3 2012 $3
Q2 2012 $-19
Q1 2012 $-10
Q4 2011 $-12
Q3 2011 $-5
Q2 2011 $10
Q1 2011 $12
Q4 2010 $6
Q3 2010 $7
Q2 2010 $11
Q1 2010 $9
Q4 2009 $12
Q3 2009 $16
Q2 2009 $11
Q1 2009 $0
Q4 2008 $36
Q3 2008 $6
Q2 2008 $8
Q1 2008 $2
Q4 2007 $-10
Q3 2007 $-17
Q2 2007 $-13
Q1 2007 $-16
Q4 2006 $-32
Q3 2006 $-6
Q2 2006 $-2
Q1 2006 $-9
Q4 2005 $-22
Q3 2005 $-14
Q2 2005 $-20
Q1 2005 $-19
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.705B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.507B 14.69
CSL (CSLLY) Australia $95.284B 0.00
Gilead Sciences (GILD) United States $92.229B 11.87
Vertex Pharmaceuticals (VRTX) United States $61.449B 55.77
Biogen (BIIB) United States $56.741B 9.69
Regeneron Pharmaceuticals (REGN) United States $46.799B 19.82
Illumina (ILMN) United States $41.325B 42.72
Alexion Pharmaceuticals (ALXN) United States $21.923B 10.20
Seattle Genetics (SGEN) United States $19.982B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Incyte (INCY) United States $17.097B 36.68
Genmab (GNMSF) Denmark $15.114B 48.61
Exact Sciences (EXAS) United States $14.140B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.768B 0.00
Galapagos (GLPG) Belgium $13.461B 34.68
Bio-Rad Laboratories (BIO.B) United States $11.564B 54.03
BeiGene (BGNE) Cayman Islands $10.013B 0.00
Sarepta Therapeutics (SRPT) United States $8.913B 0.00
QIAGEN (QGEN) Netherlands $8.278B 25.49
Guardant Health (GH) United States $7.915B 0.00
Bio-Techne Corp (TECH) United States $7.732B 52.92
BioNTech SE (BNTX) Germany $6.924B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.508B 0.00
Ascendis Pharma (ASND) Denmark $6.484B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.462B 16.43
Amarin (AMRN) Ireland $6.280B 0.00
Moderna (MRNA) United States $6.256B 0.00
Exelixis (EXEL) United States $6.132B 17.25
ARGENX SE-ADR (ARGX) Netherlands $5.957B 0.00
Reata Pharmaceuticals (RETA) United States $5.940B 0.00
Repligen (RGEN) United States $4.826B 88.29
Acceleron Pharma (XLRN) United States $4.788B 0.00
China Biologic Products (CBPO) China $4.571B 25.75
Bluebird Bio (BLUE) United States $4.240B 0.00
Adaptive Biotechnologies (ADPT) United States $3.833B 0.00
MorphoSys AG (MOR) Germany $3.741B 0.00
Mirati Therapeutics (MRTX) United States $3.499B 0.00
Immunomedics (IMMU) United States $3.427B 0.00
Blueprint Medicines (BPMC) United States $3.348B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.301B 0.00
Zai Lab (ZLAB) China $3.256B 0.00
Genmab (GMAB) Denmark $3.175B 12.45
Emergent Biosolutions (EBS) United States $3.172B 22.18
CRISPR Therapeutics AG (CRSP) Switzerland $3.162B 53.57
NeoGenomics (NEO) United States $3.161B 168.22
Momenta Pharmaceuticals (MNTA) United States $3.156B 0.00
Halozyme Therapeutics (HALO) United States $3.140B 0.00
Alkermes (ALKS) Ireland $3.119B 247.13
Intercept Pharmaceuticals (ICPT) United States $2.975B 0.00
MyoKardia (MYOK) United States $2.952B 0.00
Insmed (INSM) United States $2.667B 0.00
Amicus Therapeutics (FOLD) United States $2.650B 0.00
UniQure (QURE) Netherlands $2.546B 0.00
Arena Pharmaceuticals (ARNA) United States $2.469B 5.74
Fate Therapeutics (FATE) United States $2.318B 0.00
RA PHARMCTL INC (RARX) United States $2.197B 0.00
Denali Therapeutics (DNLI) United States $2.179B 0.00
Principia Biopharma (PRNB) United States $2.064B 0.00
Epizyme (EPZM) United States $1.971B 0.00
Alector (ALEC) United States $1.885B 0.00
REGENXBIO (RGNX) United States $1.850B 0.00
Ligand Pharmaceuticals (LGND) United States $1.758B 51.32
Arvinas (ARVN) United States $1.686B 0.00
Zymeworks (ZYME) Canada $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.577B 0.00
Coherus BioSciences (CHRS) United States $1.520B 0.00
Zealand Pharma (ZEAL) Denmark $1.414B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.399B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.399B 0.00
Myriad Genetics (MYGN) United States $1.393B 24.58
Intra-Cellular Therapies (ITCI) United States $1.275B 0.00
Editas Medicine (EDIT) United States $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.214B 0.00
Twist Bioscience (TWST) United States $1.171B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.158B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.065B 0.00
Athenex (ATNX) United States $1.057B 0.00
PHARMA MAR SA (PHMMF) Spain $0.938B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Adverum Biotechnologies (ADVM) United States $0.888B 0.00
DBV Technologies S.A (DBVT) France $0.877B 0.00
Cytokineticsorporated (CYTK) United States $0.869B 0.00
Vericel (VCEL) United States $0.844B 314.83
Mesoblast (MESO) Australia $0.843B 0.00
Sangamo Therapeutics (SGMO) United States $0.820B 0.00
Codexis (CDXS) United States $0.791B 0.00
Arcus Biosciences (RCUS) United States $0.754B 0.00
Intrexon (PGEN) United States $0.745B 0.00
Heska (HSKA) United States $0.743B 189.82
Cellectis S.A (CLLS) France $0.723B 0.00
Retrophin (RTRX) United States $0.711B 0.00
ANI Pharmaceuticals (ANIP) United States $0.710B 12.11
Cara Therapeutics (CARA) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
GENFIT S.A (GNFT) France $0.637B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.27
Intellia Therapeutics (NTLA) United States $0.615B 0.00
UROGEN PHARMA (URGN) United States $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.608B 20.78
Cel-Sci (CVM) United States $0.608B 0.00
Kadmon Holdings (KDMN) United States $0.595B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.563B 0.00
Bellus Health (BLU) Canada $0.552B 0.00
Clovis Oncology (CLVS) United States $0.544B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
AC Immune SA (ACIU) Switzerland $0.532B 12.30
NantKwest (NK) United States $0.531B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.491B 0.00
Puma Biotechnology (PBYI) United States $0.489B 0.00
Prothena (PRTA) Ireland $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.470B 0.00
Compugen (CGEN) Israel $0.468B 0.00
Agenus (AGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mersana Therapeutics (MRSN) United States $0.432B 0.00
Cue Biopharma (CUE) United States $0.428B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Precision BioSciences (DTIL) United States $0.418B 0.00
Merus (MRUS) Netherlands $0.406B 0.00
Pfenex (PFNX) United States $0.403B 0.00
Inovio Pharmaceuticals (INO) United States $0.401B 0.00
Sorrento Therapeutics (SRNE) United States $0.401B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.398B 0.00
Dynavax Technologies (DVAX) United States $0.397B 0.00
PDL BioPharma (PDLI) United States $0.392B 9.81
Avid Bioservices (CDMO) United States $0.389B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.375B 0.00
Stemline Therapeutics (STML) United States $0.333B 0.00
Gritstone Oncology (GRTS) United States $0.330B 0.00
CytomX Therapeutics (CTMX) United States $0.329B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
MannKind (MNKD) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.300B 0.00
Aduro Biotech (ADRO) United States $0.300B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Starpharma Holdings (SPHRY) Australia $0.289B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.285B 0.00
Syros Pharmaceuticals (SYRS) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.282B 0.00
Kamada (KMDA) Israel $0.262B 10.91
Novavax (NVAX) United States $0.262B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.259B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
VBI Vaccines (VBIV) United States $0.253B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Protagonist Therapeutics (PTGX) United States $0.242B 0.00
Geron (GERN) United States $0.240B 0.00
IVERIC Bio (ISEE) United States $0.237B 0.00
Kala Pharmaceuticals (KALA) United States $0.233B 0.00
ChromaDex (CDXC) United States $0.229B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Prometic Life Sciences (LMNL) Canada $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.216B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
TELA Bio (TELA) United States $0.209B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.208B 10.69
Alcobra (ARCT) United States $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.200B 0.00
Abeona Therapeutics (ABEO) United States $0.200B 0.00
Athersys (ATHX) United States $0.196B 0.00
Cerecor (CERC) United States $0.192B 0.00
Five Prime Therapeutics (FPRX) United States $0.191B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Theratechnologies (THTX) Canada $0.189B 0.00
Arbutus Biopharma (ABUS) Canada $0.188B 0.00
VolitionRX (VNRX) Singapore $0.187B 0.00
VTv Therapeutics (VTVT) United States $0.186B 0.00
Exicure (XCUR) United States $0.182B 0.00
Fortress Biotech (FBIO) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Strongbridge Biopharma (SBBP) United States $0.166B 4.45
Northwest Biotherapeutics (NWBO) United States $0.160B 0.00
Selecta Biosciences (SELB) United States $0.159B 0.00
Windtree Therapeutics (WINT) United States $0.158B 0.00
CorMedix Inc (CRMD) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.154B 0.00
Verastem (VSTM) United States $0.153B 0.00
Aptinyx (APTX) United States $0.149B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
ARAVIVE, INC (ARAV) United States $0.132B 0.00
Palatin Technologies (PTN) United States $0.131B 3.57
Antibe Therapeutics (ATBPF) Canada $0.128B 0.00
OvaScience (MLND) United States $0.127B 0.00
Menlo Therapeutics (MNLO) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
Prima BioMed (IMMP) Australia $0.112B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Happiness Biotech Group (HAPP) China $0.105B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Vaccinex (VCNX) United States $0.104B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.102B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.093B 0.00
Applied Genetic Technologies (AGTC) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Pluristem Therapeutics (PSTI) Israel $0.074B 0.00
Orgenesis (ORGS) United States $0.072B 4.63
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Trevena (TRVN) United States $0.068B 0.00
Acorda Therapeutics (ACOR) United States $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Advaxis (ADXS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
TOCAGEN INC (TOCA) United States $0.050B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.046B 0.00
Curis (CRIS) United States $0.045B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
AquaBounty Technologies (AQB) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Celsion (CLSN) United States $0.029B 0.00
Pulmatrix (PULM) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Oncobiologics (OTLK) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
VIVUS (VVUS) United States $0.025B 0.00
IBio (IBIO) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.015B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.004B 0.00